2021 October - 19 articles
Interstitial lung diseases may have an unpredictably progressive course, which is manifested as progression of pulmonary fibrosis, causing an increasing impairment of lung function affecting a poor prognosis. The possibility of an effective antifibro...
Introduction: Pulmonary blastoma is a rare malignancy, accounting for less than 0.5% of primary lung tumors. It belongs to the group of pulmonary sarcomatoid carcinomas, and it is typically characterized by a biphasic pattern of an epithelial and a m...
A 43-year-old female presented with complaints of chest pain, non-productive cough, shortness of breath, diarrhoea, loss of weight and appetite, and generalised malaise for a period of one month [...]
Introduction: Increasing evidence has declared a hypercoagulable state in the coronavirus 2019 infection (COVID-19), while the etiology has remained a question. For the first time, the current study has aimed to compare the contributors of thromboemb...
Septic pulmonary embolism (SPE) is a serious complication of fulminant bacteraemia, usually seen in immunocompromised persons or intravenous drug abusers [...]
Hydatidosis, when present in multiple thoracic locations, requires a synchronous or successive approach, which can lead to an increased risk of complications [...]
The severe acute respiratory syndrome coro‑navirus 2 (SARS‑CoV‑2), causing coronavirus disease 2019 (COVID‑19), arrived in Belgium early February 2020 [...]
As healthcare systems in many countries buckle under the immense pressure of rising COVID cases, a drug which can reduce emergency visits would be a huge boon [...]
Ever since the results of the RECOVERY trial [...]
Introduction: COVID-19-associated pulmonary sequalae have been increasingly reported after recovery from acute infection. Therefore, we aim to explore the charactersitics of persistent lung parenchymal abnormalities in patients with COVID-19. Materia...
Sclerosing pneumocytomas are one of the most common benign lung tumors [...]
Introduction: Obstructive sleep apnea syndrome (OSAS) is a highly prevalent sleep disorder associated with increased cardiovascular morbidity and mortality. This study aimed to investigate heart structure and function and their correlation with the d...
Nintedanib is an antifibrotic drug that has an inhibitory effect on growth factor tyrosine kinases. In patients with idiopathic pulmonary fibrosis and systemic scleroderma-associated interstitial pneumonia (SSc-IP), nintedanib has been effective in s...
A 35 year-old female presented to the Pulmonary Medicine OPD with a history of progressive dyspnea, malaise, weakness and easy fatigability for the last 5–6 month [...]
Introduction: Approximately one-third of patients hospitalised for an exacerbation of chronic obstructive pulmonary disease (COPD) are readmitted to the hospital within 90 days. It is of interest to identify biomarkers that predict relapse in order t...
Airway management is one of the key skills that medical personnel should master, especially by emergency medical service teams [...]
Actinomycosis is a rare disease caused by Actinomyces spp. The clinical and radiological picture of the disease is uncharacter-istic, which delays the diagnosis and can lead to complications. We present a case of pulmonary actinomycosis complicated b...
Broncholithiasis is an unusual clinical condition characterized by the presence of calcified or ossified material within the airways. Multiple endobronchial broncholithiasis during active infection with tuberculosis is an extremely uncommon presentat...
Cotton dust exposure has been implicated in causing diseases like byssinosis and obstructive airway diseases like COPD and asthma. Long-term exposure to cotton dust causing interstitial lung disease and pulmonary fibrosis has been sparsely reported i...
